Please use this identifier to cite or link to this item:
|Title:||Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients|
National Cancer Institute Thailand
Suan Dusit University
Khon Kaen University
|Keywords:||Biochemistry, Genetics and Molecular Biology;Medicine|
|Citation:||Asian Pacific Journal of Cancer Prevention. Vol.13, No.7 (2012), 3489-3493|
|Abstract:||Hepatocellular carcinoma (HCC), the most common primary hepatic tumor, is highly prevalent in the Asia-Pacific region, including Thailand. Many genetic and epigenetic alterations in HCC have been elucidated. The aim of this study was to determine whether aberrant methylation of the suppressor of cytokine signaling 1 gene (SOCS1) occurs in HCCs. Methylation specific-PCR assays were performed to identify the methylation status of SOCS1 in 29 tumors and their corresponding normal liver tissues. An abnormal methylation status was detected in 17 (59%), with a higher prevalence of aberrant SOCS1 methylation significantly correlating with HCC treated without chemotherapy (OR=0.04, 95%CI=0.01-0.31; P=0.001). This study suggests that epigenetic aberrant SOCS1 methylation may be a predictive marker for HCC patients.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.